SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-22-027117
Filing Date
2022-12-30
Accepted
2022-12-30 11:57:01
Documents
12
Period of Report
2022-12-29
Items
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

Document Format Files

Seq Description Document Type Size
1 8-K rani-20221229.htm   iXBRL 8-K 50736
  Complete submission text file 0000950170-22-027117.txt   171387

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rani-20221229.xsd EX-101.SCH 2493
3 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rani-20221229_pre.xml EX-101.PRE 10303
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rani-20221229_lab.xml EX-101.LAB 14018
6 EXTRACTED XBRL INSTANCE DOCUMENT rani-20221229_htm.xml XML 4939
Mailing Address 2051 RINGWOOD AVENUE SAN JOSE CA 95131
Business Address 2051 RINGWOOD AVENUE SAN JOSE CA 95131 (408) 457-3700
Rani Therapeutics Holdings, Inc. (Filer) CIK: 0001856725 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40672 | Film No.: 221501050
SIC: 2834 Pharmaceutical Preparations